Acute Exacerbation of Interstitial Lung Disease: Definitions, Epidemiology, Prognosis and Management.
DOI:
https://doi.org/10.58877/japaj.v2i1.125Abstract
Abstract
Acute exacerbation of interstitial ling disease (AE-ILD) denotes a rapid deterioration of respiratory function often leading to ICU admission due to severe hypoxemia. Definitions encompass the diverse spectrum of interstitial lung diseases and specific criteria for AE-ILD, originally established for idiopathic pulmonary fibrosis (IPF) and later expanded to other interstitial lung diseases. The incidence varies among the various interstitial lung disease subtypes, with around 10% of interstitial lung disease patients experiencing acute exacerbations within the initial two years of diagnosis. Clinical risk factors encompass advanced interstitial lung disease, compromised pulmonary function, and coexisting conditions.
Prognostic markers include baseline pulmonary parameters, blood markers, and a newly developed Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) staging system. However, due to the scarcity of randomized studies, optimal treatment strategies remain uncertain. Current guidelines propose supportive care and oxygen therapy, with cautious use of corticosteroids in AE-IPF. Antibiotics are employed to manage infections, with procalcitonin-guided therapy showing potential.
Management involves exposure elimination, targeted antibiotics, and antacid and antifibrotic use. For severe cases, mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and even transplantation are considered.
To conclude, AE-ILD poses formidable challenges and high mortality rates. Given the lack of standardized approaches, the pursuit of randomized trials is vital to enhance the understanding and management of AE-ILD, optimizing patient outcomes within the ICU setting.
Keywords: acute exacerbation, interstitial lung disease, idiopathic pulmonary fibrosis, intensive care unit, definition.
References
Al-hameed FM, Sharma S. Outcome of Patients Admitted to Intensive Care Unit for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Can Respir J. NaN/NaN/NaN;11:117–22. DOI: https://doi.org/10.1155/2004/379723
Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006 Jan 1;27(1):143–50. DOI: https://doi.org/10.1183/09031936.06.00114004
Leuschner G, Behr J. Acute Exacerbation in Interstitial Lung Disease. Front Med. 2017 Oct 23;4:176. DOI: https://doi.org/10.3389/fmed.2017.00176
Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011 Feb 1;37(2):356–63. DOI: https://doi.org/10.1183/09031936.00159709
Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2007 Oct;176(7):636–43. DOI: https://doi.org/10.1164/rccm.200703-463PP
Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016 Aug;194(3):265–75. DOI: https://doi.org/10.1164/rccm.201604-0801CI
Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, et al. Acute Exacerbation of Interstitial Pneumonia Other Than Idiopathic Pulmonary Fibrosis. Chest. 2007 Jul 1;132(1):214–20. DOI: https://doi.org/10.1378/chest.07-0323
Suzuki A, Kondoh Y, Brown KK, Johkoh T, Kataoka K, Fukuoka J, et al. Acute exacerbations of fibrotic interstitial lung diseases. Respirology. 2020;25(5):525–34. DOI: https://doi.org/10.1111/resp.13682
Oda K, Ishimoto H, Yamada S, Kushima H, Ishii H, Imanaga T, et al. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis. Respir Res. 2014 Sep 1;15(1):109. DOI: https://doi.org/10.1186/s12931-014-0109-y
Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 2009 Jun;103(6):846–53. DOI: https://doi.org/10.1016/j.rmed.2008.12.019
Miyazaki Y, Tateishi T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Clinical Predictors and Histologic Appearance of Acute Exacerbations in Chronic Hypersensitivity Pneumonitis. Chest. 2008 Dec 1;134(6):1265–70. DOI: https://doi.org/10.1378/chest.08-0866
Rice AJ, Wells AU, Bouros D, du Bois RM, Hansell DM, Polychronopoulos V, et al. Terminal Diffuse Alveolar Damage in Relation to Interstitial Pneumonias: An Autopsy Study. Am J Clin Pathol. 2003 May 1;119(5):709–14. DOI: https://doi.org/10.1309/UVARMDY8FE9FJDKU
Izuka S, Yamashita H, Iba A, Takahashi Y, Kaneko H. Acute exacerbation of rheumatoid arthritis–associated interstitial lung disease: clinical features and prognosis. Rheumatology. 2021 May 1;60(5):2348–54. DOI: https://doi.org/10.1093/rheumatology/keaa608
Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol. 1997 Jan;168(1):79–83. DOI: https://doi.org/10.2214/ajr.168.1.8976924
Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Janssen WJ, Schwarz MI, et al. Acute Exacerbations of Fibrotic Hypersensitivity Pneumonitis: A Case Series. Chest. 2008 Oct 1;134(4):844–50. DOI: https://doi.org/10.1378/chest.08-0428
Ryerson CJ, Cottin V, Brown KK, Collard HR. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm. Eur Respir J. 2015 Aug 1;46(2):512–20. DOI: https://doi.org/10.1183/13993003.00419-2015
Atkins CP, Loke YK, Wilson AM. Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials. Respir Med. 2014 Feb 1;108(2):376–87. DOI: https://doi.org/10.1016/j.rmed.2013.11.007
Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res. 2013;14(1):73. DOI: https://doi.org/10.1186/1465-9921-14-73
Bando M, Ohno S, Hosono T, Yanase K, Sato Y, Sohara Y, et al. Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease. J Bronchol Interv Pulmonol. 2009 Oct;16(4):229. DOI: https://doi.org/10.1097/LBR.0b013e3181b767cc
Sakamoto S, Homma S, Mun M, Fujii T, Kurosaki A, Yoshimura K. Acute Exacerbation of Idiopathic Interstitial Pneumonia Following Lung Surgery in 3 of 68 Consecutive Patients: A Retrospective Study. Intern Med. 2011;50(2):77–85. DOI: https://doi.org/10.2169/internalmedicine.50.3390
Samejima J, Tajiri M, Ogura T, Baba T, Omori T, Tsuboi M, et al. Thoracoscopic lung biopsy in 285 patients with diffuse pulmonary disease. Asian Cardiovasc Thorac Ann. 2015 Feb;23(2):191–7. DOI: https://doi.org/10.1177/0218492314550724
Amundson WH, Racila E, Allen T, Dincer HE, Tomic R, Bhargava M, et al. Acute exacerbation of interstitial lung disease after procedures. Respir Med. 2019 Apr 1;150:30–7. DOI: https://doi.org/10.1016/j.rmed.2019.02.012
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788–824.
Kuhn C, Boldt J, King TE, Crouch E, Vartio T, McDonald JA. An Immunohistochemical Study of Architectural Remodeling and Connective Tissue Synthesis in Pulmonary Fibrosis. Am Rev Respir Dis. 1989 Dec;140(6):1693–703. DOI: https://doi.org/10.1164/ajrccm/140.6.1693
Dafforn TR, Della M, Miller AD. The Molecular Interactions of Heat Shock Protein 47 (Hsp47) and Their Implications for Collagen Biosynthesis *. J Biol Chem. 2001 Dec 28;276(52):49310–9. DOI: https://doi.org/10.1074/jbc.M108896200
Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, et al. Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2009 Apr;179(7):588–94. DOI: https://doi.org/10.1164/rccm.200810-1534OC
Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, et al. Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses. Am J Respir Crit Care Med. 2013 Apr 1;187(7):768–75. DOI: https://doi.org/10.1164/rccm.201203-0506OC
Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014 Apr;43(4):1124–31. DOI: https://doi.org/10.1183/09031936.00122213
Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis. CHEST. 2016 May 1;149(5):1205–14. DOI: https://doi.org/10.1016/j.chest.2015.12.026
Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: Aetiology and outcomes. Respirology. 2010;15(6):909–17. DOI: https://doi.org/10.1111/j.1440-1843.2010.01774.x
Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, et al. Anti-Acid Therapy and Disease Progression in Idiopathic Pulmonary Fibrosis: an analysis of data from three randomized controlled trials. Lancet Respir Med. 2013 Jul;1(5):369–76. DOI: https://doi.org/10.1016/S2213-2600(13)70105-X
Simon-Blancal V, Freynet O, Nunes H, Bouvry D, Naggara N, Brillet PY, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors. Respiration. 2011 Aug 23;83(1):28–35. DOI: https://doi.org/10.1159/000329891
Petrosyan F, Culver DA, Reddy AJ. Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: a retrospective study. BMC Pulm Med. 2015 Jul 10;15(1):70. DOI: https://doi.org/10.1186/s12890-015-0066-3
Mizuno Y, Iwata H, Shirahashi K, Takamochi K, Oh S, Suzuki K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg. 2012 Jun 1;41(6):e161–5. DOI: https://doi.org/10.1093/ejcts/ezs147
Schupp JC, Binder H, Jäger B, Cillis G, Zissel G, Müller-Quernheim J, et al. Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. PLoS ONE. 2015 Jan 15;10(1):e0116775. DOI: https://doi.org/10.1371/journal.pone.0116775
Kondoh Y, Taniguchi H, Ebina M, Azuma A, Ogura T, Taguchi Y, et al. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis – Extended analysis of pirfenidone trial in Japan. Respir Investig. 2015 Nov 1;53(6):271–8. DOI: https://doi.org/10.1016/j.resinv.2015.04.005
Kondoh Y, Taniguchi H, Katsuta T, Kataoka K, Kimura T, Nishiyama O, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2010 Jul;27(2):103–10. DOI: https://doi.org/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A1107
Reichmann WM, Yu YF, Macaulay D, Wu EQ, Nathan SD. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Dec 29;15:167. DOI: https://doi.org/10.1186/s12890-015-0161-5
Judge EP, Fabre A, Adamali HI, Egan JJ. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J. 2012 Jul;40(1):93–100. DOI: https://doi.org/10.1183/09031936.00115511
Kakiuchi S, Hanibuchi M, Tezuka T, Saijo A, Otsuka K, Sakaguchi S, et al. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1. Respir Investig. 2017 Mar 1;55(2):145–52. DOI: https://doi.org/10.1016/j.resinv.2016.10.008
Takei R, Arita M, Kumagai S, Ito Y, Noyama M, Tokioka F, et al. Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia. BMC Pulm Med [Internet]. 2017 [cited 2023 Jul 20];17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397815/ DOI: https://doi.org/10.1186/s12890-017-0412-8
Kishaba T, Tamaki H, Shimaoka Y, Fukuyama H, Yamashiro S. Staging of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis. Lung. 2014 Feb 1;192(1):141–9. DOI: https://doi.org/10.1007/s00408-013-9530-0
Charokopos A, Moua T, Ryu JH, Smischney NJ. Acute exacerbation of interstitial lung disease in the intensive care unit. World J Crit Care Med. 2022 Jan 9;11(1):22–32. DOI: https://doi.org/10.5492/wjccm.v11.i1.22
Akira M, Kozuka T, Yamamoto S, Sakatani M. Computed Tomography Findings in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2008 Aug 15;178(4):372–8. DOI: https://doi.org/10.1164/rccm.200709-1365OC
Tachikawa R, Tomii K, Ueda H, Nagata K, Nanjo S, Sakurai A, et al. Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic. Respiration. 2011 Sep 6;83(1):20–7. DOI: https://doi.org/10.1159/000329893
Papiris SA, Kagouridis K, Kolilekas L, Papaioannou AI, Roussou A, Triantafillidou C, et al. Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach. BMC Pulm Med. 2015 Dec 14;15(1):162. DOI: https://doi.org/10.1186/s12890-015-0146-4
Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF. Respirology. 2020;25(6):629–35. DOI: https://doi.org/10.1111/resp.13753
Walkey AJ, Wiener RS. Macrolide Antibiotics and Survival in Patients With Acute Lung Injury. Chest. 2012 May;141(5):1153–9. DOI: https://doi.org/10.1378/chest.11-1908
Kawamura K, Ichikado K, Suga M, Yoshioka M. Efficacy of Azithromycin for Treatment of Acute Exacerbation of Chronic Fibrosing Interstitial Pneumonia: A Prospective, Open-Label Study with Historical Controls. Respiration. 2014 Apr 30;87(6):478–84. DOI: https://doi.org/10.1159/000358443
Ding J, Chen Z, Feng K. Procalcitonin-Guided Antibiotic Use in Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Int J Med Sci. 2013 May 20;10(7):903–7. DOI: https://doi.org/10.7150/ijms.4972
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, et al. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. N Engl J Med. 2011 Sep 22;365(12):1079–87. DOI: https://doi.org/10.1056/NEJMoa1103690
Briones - Claudett KH, Claudett M, Domenica E, Garcia S, Solis J, Cabrera C, et al. Volume-Assured Pressure Support Mode Plus Pirfenidone as Resuscitation Therapy in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis. Adv Respir Med. 2020 Apr 30;88:147–52. DOI: https://doi.org/10.5603/ARM.2020.0077
Toyoda Y, Hanibuchi M, Kishi J, Kawano H, Morizumi S, Sato S, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease. J Med Invest. 2016;63(3.4):294–9. DOI: https://doi.org/10.2152/jmi.63.294
Sakamoto S, Homma S, Miyamoto A, Kurosaki A, Fujii T, Yoshimura K. Cyclosporin A in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Intern Med. 2010;49(2):109–15. DOI: https://doi.org/10.2169/internalmedicine.49.2359
Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, et al. Cyclosporin Treatment in Steroid-resistant and Acutely Exacerbated Interstitial Pneumonia. Intern Med. 2005;44(11):1144–50. DOI: https://doi.org/10.2169/internalmedicine.44.1144
Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure. N Engl J Med. 2015 Jun 4;372(23):2185–96. DOI: https://doi.org/10.1056/NEJMoa1503326
Horio Y, Takihara T, Niimi K, Komatsu M, Sato M, Tanaka J, et al. High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series. Respir Investig. 2016 Mar 1;54(2):125–9. DOI: https://doi.org/10.1016/j.resinv.2015.09.005
Koyauchi T, Hasegawa H, Kanata K, Kakutani T, Amano Y, Ozawa Y, et al. Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study. Respiration. 2018 Jun 28;96(4):323–9. DOI: https://doi.org/10.1159/000489890
Vianello A, Arcaro G, Battistella L, Pipitone E, Vio S, Concas A, et al. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care. 2014 Aug 1;29(4):562–7. DOI: https://doi.org/10.1016/j.jcrc.2014.03.019
Yokoyama T, Kondoh Y, Taniguchi H, Kataoka K, Kato K, Nishiyama O, et al. Noninvasive Ventilation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Intern Med. 2010;49(15):1509–14. DOI: https://doi.org/10.2169/internalmedicine.49.3222
Disayabutr S, Calfee CS, Collard HR, Wolters PJ. Interstitial lung diseases in the hospitalized patient. BMC Med. 2015 Sep 25;13(1):245. DOI: https://doi.org/10.1186/s12916-015-0487-0
Moerer O, Quintel M. Bridge or Abyss: Extracorporeal Membrane Oxygenation for Acute Respiratory Failure in Interstitial Lung Disease. Am J Respir Crit Care Med. 2016 Mar;193(5):474–6. DOI: https://doi.org/10.1164/rccm.201511-2184ED
Todd EM, Roy SB, Hashimi AS, Serrone R, Panchanathan R, Kang P, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: A single-center experience in the present era. J Thorac Cardiovasc Surg. 2017 Nov 1;154(5):1798–809. DOI: https://doi.org/10.1016/j.jtcvs.2017.06.063
Rangappa P, Moran JL. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. Crit Care Resusc J Australas Acad Crit Care Med. 2009 Jun;11(2):102–9. DOI: https://doi.org/10.1016/S1441-2772(23)01533-8
Saydain G, Islam A, Afessa B, Ryu JH, Scott JP, Peters SG. Outcome of Patients with Idiopathic Pulmonary Fibrosis Admitted to the Intensive Care Unit. Am J Respir Crit Care Med. 2002 Sep 15;166(6):839–42. DOI: https://doi.org/10.1164/rccm.2104038
Rush B, Wiskar K, Berger L, Griesdale D. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: A nationwide retrospective cohort analysis. Respir Med. 2016 Feb 1;111:72–6. DOI: https://doi.org/10.1016/j.rmed.2015.12.005
Schrader M, Sathananthan M, Jeganathan N. Patients With Idiopathic Pulmonary Fibrosis Admitted to the ICU With Acute Respiratory Failure—A Reevaluation of the Risk Factors and Outcomes. J Intensive Care Med. 2022 Mar 1;37(3):342–51. DOI: https://doi.org/10.1177/0885066621989244
Gaudry S, Vincent F, Rabbat A, Nunes H, Crestani B, Naccache JM, et al. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg. 2014 Jan 1;147(1):47–53. DOI: https://doi.org/10.1016/j.jtcvs.2013.06.039
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 JAP Academy Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
